KMDA
Price
$5.97
Change
-$0.31 (-4.94%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
306.49M
52 days until earnings call
SGIOY
Price
$7.62
Change
+$0.14 (+1.87%)
Updated
Apr 3 closing price
Capitalization
12.4B
32 days until earnings call
Ad is loading...

KMDA vs SGIOY

Header iconKMDA vs SGIOY Comparison
Open Charts KMDA vs SGIOYBanner chart's image
Kamada
Price$5.97
Change-$0.31 (-4.94%)
Volume$525
Capitalization306.49M
Shionogi & Co
Price$7.62
Change+$0.14 (+1.87%)
Volume$102.82K
Capitalization12.4B
KMDA vs SGIOY Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. SGIOY commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and SGIOY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (KMDA: $6.28 vs. SGIOY: $7.62)
Brand notoriety: KMDA and SGIOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 56% vs. SGIOY: 123%
Market capitalization -- KMDA: $306.49M vs. SGIOY: $12.4B
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. SGIOY’s [@Pharmaceuticals: Other] market capitalization is $12.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileSGIOY’s FA Score has 2 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • SGIOY’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than KMDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 3 TA indicator(s) are bullish while SGIOY’s TA Score has 2 bullish TA indicator(s).

  • KMDA’s TA Score: 3 bullish, 6 bearish.
  • SGIOY’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, SGIOY is a better buy in the short-term than KMDA.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а -8.05% price change this week, while SGIOY (@Pharmaceuticals: Other) price change was -0.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.71%. For the same industry, the average monthly price growth was -3.64%, and the average quarterly price growth was -11.61%.

Reported Earning Dates

KMDA is expected to report earnings on May 27, 2025.

SGIOY is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.71% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOY($12.4B) has a higher market cap than KMDA($306M). KMDA has higher P/E ratio than SGIOY: KMDA (37.43) vs SGIOY (9.62). SGIOY YTD gains are higher at: 9.448 vs. KMDA (6.075). SGIOY has higher annual earnings (EBITDA): 242B vs. KMDA (22.4M). SGIOY has more cash in the bank: 563B vs. KMDA (55.6M). KMDA has less debt than SGIOY: KMDA (8.82M) vs SGIOY (9.41B). SGIOY has higher revenues than KMDA: SGIOY (427B) vs KMDA (143M).
KMDASGIOYKMDA / SGIOY
Capitalization306M12.4B2%
EBITDA22.4M242B0%
Gain YTD6.0759.44864%
P/E Ratio37.439.62389%
Revenue143M427B0%
Total Cash55.6M563B0%
Total Debt8.82M9.41B0%
FUNDAMENTALS RATINGS
KMDA vs SGIOY: Fundamental Ratings
KMDA
SGIOY
OUTLOOK RATING
1..100
8062
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
8498
SMR RATING
1..100
812
PRICE GROWTH RATING
1..100
4252
P/E GROWTH RATING
1..100
8068
SEASONALITY SCORE
1..100
26n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOY's Valuation (25) in the null industry is somewhat better than the same rating for KMDA (72) in the Biotechnology industry. This means that SGIOY’s stock grew somewhat faster than KMDA’s over the last 12 months.

KMDA's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as SGIOY (98) in the null industry. This means that KMDA’s stock grew similarly to SGIOY’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for KMDA (81) in the Biotechnology industry. This means that SGIOY’s stock grew significantly faster than KMDA’s over the last 12 months.

KMDA's Price Growth Rating (42) in the Biotechnology industry is in the same range as SGIOY (52) in the null industry. This means that KMDA’s stock grew similarly to SGIOY’s over the last 12 months.

SGIOY's P/E Growth Rating (68) in the null industry is in the same range as KMDA (80) in the Biotechnology industry. This means that SGIOY’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDASGIOY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 11 days ago
66%
Declines
ODDS (%)
Bearish Trend 5 days ago
66%
Bearish Trend 5 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPGX7.630.04
+0.54%
Invesco SteelPath MLP Alpha C
SUWAX32.14N/A
N/A
DWS Core Equity A
ABWYX15.27N/A
N/A
AB All Market Total Return Advisor
LSEIX15.10N/A
N/A
Persimmon Long/Short I
RPMNX17.93N/A
N/A
Reinhart Mid Cap PMV Institutional

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and INCR have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and INCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-6.41%
INCR - KMDA
27%
Poorly correlated
-2.54%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
+1.84%
RDY - KMDA
23%
Poorly correlated
+0.08%
OGI - KMDA
23%
Poorly correlated
-4.79%
More

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+1.84%
TAK - SGIOY
40%
Loosely correlated
+1.40%
ESAIY - SGIOY
36%
Loosely correlated
+0.15%
KMDA - SGIOY
27%
Poorly correlated
-6.41%
SCYX - SGIOY
23%
Poorly correlated
-5.20%
SUPN - SGIOY
22%
Poorly correlated
-1.01%
More